©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 108047
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.108047
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.108047
Table 7 Antibiotic treatment of the children of different age groups with Mycoplasma pneumoniae pneumonia, n (%)
| Age group (years) | SMPP (n = 264) | GMPP (n = 896) | P value | ||||||
| Total, n | Mono macrolides | Combined antibiotic therapy | P value | Total, n | Mono macrolides | Combined antibiotic therapy | P value | ||
| 0-1 | 13 | 4 (30.8) | 9 (69.2) | 0.117 | 38 | 9 (23.7) | 29 (76.3) | < 0.001 | 0.891a, 0.891b |
| 2-5 | 49 | 10 (20.4) | 39 (79.6) | < 0.001 | 164 | 51 (31.1) | 113 (68.9) | < 0.001 | 0.146a, 0.146b |
| 6-15 | 202 | 28 (13.9) | 174 (86.1) | < 0.001 | 694 | 144 (20.7) | 550 (79.3) | < 0.001 | 0.029a, 0.029b |
| Total | 264 | 42 (15.9) | 222 (84.1) | < 0.001 | 896 | 204 (22.8) | 692 (77.2) | < 0.001 | 0.017a, 0.017b |
- Citation: Bi J, Li X, Tang H, Kalinina O, Jiang TT, Jiao WW, Zeng X, Dmitriev A, Shen A. Comprehensive study of community acquired Mycoplasma pneumoniae pneumonia in children in Baoding, China, 2023. World J Clin Pediatr 2025; 14(4): 108047
- URL: https://www.wjgnet.com/2219-2808/full/v14/i4/108047.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.108047